Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. (Q51361913)

4 April 2018

title

Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. (English)

1 reference

4 April 2018

author

Riccardo C Bonadonna

3

1 reference

4 April 2018

author name string

J J Meier

1

1 reference

4 April 2018

T G K Breuer

2

1 reference

4 April 2018

A Tannapfel

4

1 reference

4 April 2018

W Uhl

5

1 reference

4 April 2018

W E Schmidt

6

1 reference

4 April 2018

H Schrader

7

1 reference

4 April 2018

B A Menge

8

1 reference

4 April 2018

publication date

1 May 2012

1 reference

4 April 2018

published in

Diabetologia

1 reference

4 April 2018

volume

55

1 reference

4 April 2018

issue

5

1 reference

4 April 2018

page(s)

1346-1354

1 reference

4 April 2018

https://scigraph.springernature.com/pub.10.1007/s00125-012-2466-8

exact match

0 references

cites work

Metabolic control and B cell function in patients with insulin-dependent diabetes mellitus secondary to chronic pancreatitis.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Reduced pancreatic volume and beta-cell area in patients with chronic pancreatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Determinants of glucose control in patients with chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Amino acid malnutrition in patients with chronic pancreatitis and pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Nutrition in pancreatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Links between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Functional assessment of pancreatic beta-cell area in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Islet beta-cell area and hormone expression are unaltered in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Screening for insulitis in adult autoantibody-positive organ donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic beta-cell mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

A model for glucose control of insulin secretion during 24 h of free living

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Relationship between fractional pancreatic beta cell area and fasting plasma glucose concentration in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Partial pancreatectomy in adult humans does not provoke beta-cell regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Adaptive beta-cell proliferation is severely restricted with advanced age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Natural course of chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Relationship between beta-cell mass and fasting blood glucose concentration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2466-8

Prior streptozotocin treatment does not inhibit pancreas regeneration after 90% pancreatectomy in rats

21 January 2018

1 reference

12 December 2020

beta-cell adaptation in 60% pancreatectomy rats that preserves normoinsulinemia and normoglycemia

1 reference

12 December 2020

Pancreatic hormone secretion in chronic pancreatitis without residual beta-cell function

1 reference

12 December 2020

Measurements of insulin responses as predictive markers of pancreatic beta-cell mass in normal and beta-cell-reduced lean and obese Göttingen minipigs in vivo.

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

10.1007/S00125-012-2466-8

Identifiers

DOI

1 reference

4 April 2018

PubMed ID

22286529

1 reference

4 April 2018